Skip to main content
OpenTrials

Clinical trial condition

Cerebral Adrenoleukodystrophy (cALD)

Explore clinical trials studying Cerebral Adrenoleukodystrophy (cALD). Study availability and eligibility vary by location and protocol.

5 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Cerebral Adrenoleukodystrophy (cALD) trial results

Recruiting

A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adult Male Subjects With Cerebral Adrenoleukodystrophy

NCT05819866

Conditions
Cerebral Adrenoleukodystrophy (cALD)
Locations
  • Stanford University Medical Center Palo Alto, California, United States
  • Neuro Medicine Hospital / UF Health Gainesville, Florida, United States
  • Kennedy Krieger Institute Baltimore, Maryland, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View all 13 locations
View Trial Details
Completed

A Clinical Study to Assess the Efficacy and Safety of Gene Therapy for the Treatment of Cerebral Adrenoleukodystrophy (CALD)

NCT03852498

Conditions
Adrenal Gland Diseases, Adrenal Insufficiency, Adrenoleukodystrophy, +22 more
Locations
  • Lucile Packard Children's Hospital Palo Alto, California, United States
  • Boston Children's Hospital/Massachusetts General Hospital Boston, Massachusetts, United States
  • University of Minnesota Minneapolis, Minnesota, United States
  • Hôpital Robert Debré Paris, France
View Trial Details
Completed

A Study of the Efficacy and Safety of Hematopoietic Stem Cells Transduced With Lenti-D Lentiviral Vector for the Treatment of Cerebral Adrenoleukodystrophy (CALD)

NCT01896102

Conditions
Adrenal Gland Diseases, Adrenal Insufficiency, Adrenoleukodystrophy, +22 more
Locations
  • Mattel Children's Hospital UCLA/Ronald Reagan UCLA Medical Center Los Angeles, California, United States
  • Boston Children's Hospital/Massachusetts General Hospital Boston, Massachusetts, United States
  • University of Minnesota Minneapolis, Minnesota, United States
  • Medeos SRL Buenos Aires, Argentina
View Trial Details
Active, Not Recruiting

Long-term Follow-up of Participants With Cerebral Adrenoleukodystrophy Who Were Treated With Lenti-D Drug Product

NCT02698579

Conditions
Adrenal Gland Diseases, Adrenal Insufficiency, Adrenoleukodystrophy, +24 more
Locations
  • Mattel Children's Hospital-UCLA Los Angeles, California, United States
  • Lucile Packard Children's Hospital - Stanford Palo Alto, California, United States
  • Boston Children's Hospital/Massachusetts General Hospital Boston, Massachusetts, United States
  • University of Minnesota Minneapolis, Minnesota, United States
View all 13 locations
View Trial Details

Related conditions